Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Journal of Medicinal Chemistry
|
January 5, 1996
Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams
G J Bridger, R T Skerlj, S Padmanabhan, et al.
Inorganic Chemistry
|
March 18, 2003
Ruthenium(III) polyaminocarboxylate complexes: efficient and effective nitric oxide scavengers
Beth R Cameron, Marilyn C Darkes, Helen Yee, et al.
Journal of the American Chemical Society
|
September 28, 2011
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approach
Markus Metz, Elyse Bourque, Jean Labrecque, et al.
Virology
|
March 11, 2011
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assay
Jean Labrecque, Markus Metz, Gloria Lau, et al.
Journal of Medicinal Chemistry
|
January 2, 2010
Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication
Gary J Bridger, Renato T Skerlj, Pedro E Hernandez-Abad, et al.
Journal of Medicinal Chemistry
|
March 20, 2010
Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication
Renato T Skerlj, Gary J Bridger, Al Kaller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
Craig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Biochemical Pharmacology
|
December 8, 2011
The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor
Renee M Mosi, Virginia Anastassova, Jennifer Cox, et al.
Biochemical Pharmacology
|
June 23, 2009
Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4
Veronique Bodart, Virginia Anastassov, Marilyn C Darkes, et al.
Berliner Und Munchener Tierarztliche Wochenschrift
|
October 30, 2009
Neonatal health in calves--comprehensive solutions for complex enteric disorders
B Makoschey, W Klee, V Martella, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Journal of Medicinal Chemistry
|
January 5, 1996
Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication. 2. Effect of heteroaromatic linkers on the activity of bicyclams
G J Bridger, R T Skerlj, S Padmanabhan, et al.
Inorganic Chemistry
|
March 18, 2003
Ruthenium(III) polyaminocarboxylate complexes: efficient and effective nitric oxide scavengers
Beth R Cameron, Marilyn C Darkes, Helen Yee, et al.
Journal of the American Chemical Society
|
September 28, 2011
Prospective CCR5 small molecule antagonist compound design using a combined mutagenesis/modeling approach
Markus Metz, Elyse Bourque, Jean Labrecque, et al.
Virology
|
March 11, 2011
HIV-1 entry inhibition by small-molecule CCR5 antagonists: a combined molecular modeling and mutant study using a high-throughput assay
Jean Labrecque, Markus Metz, Gloria Lau, et al.
Journal of Medicinal Chemistry
|
January 2, 2010
Synthesis and structure-activity relationships of azamacrocyclic C-X-C chemokine receptor 4 antagonists: analogues containing a single azamacrocyclic ring are potent inhibitors of T-cell tropic (X4) HIV-1 replication
Gary J Bridger, Renato T Skerlj, Pedro E Hernandez-Abad, et al.
Journal of Medicinal Chemistry
|
March 20, 2010
Discovery of novel small molecule orally bioavailable C-X-C chemokine receptor 4 antagonists that are potent inhibitors of T-tropic (X4) HIV-1 replication
Renato T Skerlj, Gary J Bridger, Al Kaller, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
Craig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Biochemical Pharmacology
|
December 8, 2011
The molecular pharmacology of AMD11070: an orally bioavailable CXCR4 HIV entry inhibitor
Renee M Mosi, Virginia Anastassova, Jennifer Cox, et al.
Biochemical Pharmacology
|
June 23, 2009
Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4
Veronique Bodart, Virginia Anastassov, Marilyn C Darkes, et al.
Berliner Und Munchener Tierarztliche Wochenschrift
|
October 30, 2009
Neonatal health in calves--comprehensive solutions for complex enteric disorders
B Makoschey, W Klee, V Martella, et al.
Page
of 7